pharmaceuticals
pharmaceuticals Articles
Raptor Pharmaceuticals saw its shares sink on Monday after it announced its first commercial sale of Quinsair in Germany and Denmark.
Published:
Last Updated:
Viamet Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Insys Therapeutics watched its stock slide early Monday morning following the release of less-than-favorable revenue estimates.
Published:
Last Updated:
Over the past week, Valeant Pharmaceuticals and a few other biotech companies made impressive runs.
Published:
Last Updated:
Depomed saw its stock surge early Friday morning following news of an open letter from activist firm Starboard Value.
Published:
Last Updated:
If the momentum in biotech can continue, then companies with catalysts within the next 12 to 18 months could get an added boost with any good news.
Published:
Last Updated:
Ionis Pharmaceuticals made waves in the market on Thursday following a business update on its IONIS-TTR program.
Published:
Last Updated:
This week's top U.S. growth calls from the analysts at Jefferies focus on companies that have some outstanding upside potential, including the following three leading biotech stocks.
Published:
Last Updated:
At the end of March, a district court granted the request from Depomed and lifted the stay of its patent infringement suit against Purdue.
Published:
Last Updated:
Not only does Aldeyra Therapeutics have a good cash position, but it also it has a strong pipeline as well. One key analyst has decided to weigh in on the firm and where it stands to go from here.
Published:
Last Updated:
Over the past week, Opko Health, Acadia Pharmaceuticals and a few other biotech companies made impressive runs.
Published:
Last Updated:
Akari Therapeutics has announced preliminary results from the first paroxysmal nocturnal hemoglobinuria patient treated with subcutaneously administered Coversin.
Published:
Last Updated:
Regeneron Pharmaceuticals has announced that two Phase 3 studies evaluating investigational dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis met their...
Published:
Last Updated:
Genocea Biosciences soared early on Thursday, following the release of positive data from its mid-stage genital herpes clinical trial.
Published:
Last Updated:
Opko Health saw its shares slide in Wednesday’s regular trading session following the release of a complete response letter from the FDA.
Published:
Last Updated: